Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience
- PMID: 2236164
Dose intensification using combination alkylating agents and autologous bone marrow support in the treatment of primary and metastatic breast cancer: a review of the Duke Bone Marrow Transplantation Program experience
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical